Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hypertension × Nitroprusside × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Lymphoma 1 Leukemia 1 Leiomyoma 1 Hypertension 1 Breast Neoplasms 1

Interventions

relacorilant 5 Hydrochlorothiazide 4 Nutrition Assessment 3 Bevacizumab 3 Amlodipine 3 aliskiren 2 Osilodrostat 2 Lisinopril 2 Labetalol 2 Angiotensin-Converting Enzyme Inhibitors 2 ziprasidone 1 sacubitril and valsartan sodium hydrate drug combination 1 pembrolizumab 1 pazopanib 1 lutetium Lu 177 dotatate 1 gallium Ga 68 dotatate 1 fimasartan 1 enzalutamide 1 clevidipine 1 bicalutamide 1 benazepril 1 Zolpidem 1 Warfarin 1 Vitamin D 1 Vecuronium Bromide 1 Vancomycin 1 Urine Specimen Collection 1 Tranexamic Acid 1 Tobramycin 1 Thiazides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01125943 2013-01-10

Bevacizumab and Endothelium Dependent Vasodilation

Radboud University Medical Center

Phase NA Completed

Hypertension, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡